Hu Lane Associate Inc. (TPEX:6279)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	15,415	18,082	15,845	14,400	13,952	11,361
Market Cap Growth	-3.37%	14.12%	10.04%	3.21%	22.81%	30.41%
Enterprise Value	17,219	20,081	18,036	15,967	14,694	11,832
Last Close Price	136.00	176.00	150.33	131.40	123.38	97.15
PE Ratio	11.62	13.80	17.20	14.40	17.69	20.38
Forward PE	10.97	13.91	15.08	13.23	16.00	19.07
PS Ratio	1.67	2.06	2.16	2.21	2.82	3.11
PB Ratio	1.75	2.44	2.59	2.58	2.79	2.46
P/TBV Ratio	1.77	2.47	2.63	2.61	2.81	2.47
P/FCF Ratio	-	-	-	-	-	156.62
P/OCF Ratio	12.14	14.27	11.06	18.19	23.59	18.75
EV/Sales Ratio	1.86	2.28	2.46	2.45	2.97	3.24
EV/EBITDA Ratio	7.61	9.45	10.60	11.44	11.69	12.37
EV/EBIT Ratio	10.45	12.70	14.77	15.39	15.19	17.06
EV/FCF Ratio	-31.07	-	-	-	-	163.12
Debt / Equity Ratio	0.33	0.51	0.52	0.53	0.31	0.27
Debt / EBITDA Ratio	1.31	1.74	1.81	2.08	1.22	1.28
Debt / FCF Ratio	-	-	-	-	-	17.06
Asset Turnover	0.70	0.69	0.65	0.68	0.65	0.53
Inventory Turnover	3.05	3.01	2.80	2.93	3.06	2.91
Quick Ratio	1.13	1.15	1.27	0.85	0.96	1.23
Current Ratio	1.63	1.63	1.80	1.29	1.49	1.65
Return on Equity (ROE)	17.23%	19.44%	15.86%	18.95%	16.54%	12.50%
Return on Assets (ROA)	7.69%	7.69%	6.77%	6.77%	7.94%	6.26%
Return on Capital (ROIC)	9.43%	9.67%	8.58%	8.60%	9.75%	7.49%
Return on Capital Employed (ROCE)	18.00%	17.90%	15.50%	17.10%	18.50%	14.40%
Earnings Yield	8.53%	7.25%	5.81%	6.94%	5.65%	4.91%
FCF Yield	-3.59%	-2.20%	-0.60%	-1.90%	0.00%	0.64%
Dividend Yield	3.68%	-	-	4.16%	3.95%	4.02%
Payout Ratio	42.73%	38.02%	60.58%	49.83%	50.55%	52.32%
Buyback Yield / Dilution	-5.25%	-7.71%	-3.02%	-0.07%	0.13%	0.03%
Total Shareholder Return	-1.52%	-7.71%	-3.02%	4.09%	4.08%	4.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.